Stock Research: Knight Therapeutics

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Knight Therapeutics

TOR:GUD CA4990531069
28
  • Value
    54
  • Growth
    19
  • Safety
    Safety
    76
  • Combined
    51
  • Sentiment
    29
  • 360° View
    360° View
    28
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Knight Therapeutics Inc. is a specialty pharmaceutical company. It operates in the pharmaceutical industry, developing, acquiring, and distributing pharmaceutical products. The company operates in Canada, Latin America, and select international markets. In the last fiscal year, the company had a market cap of $442 million, profits of $121 million, and revenue of $258 million, with 745 employees.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 19-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
54 41 39 45
Growth
19 29 41 15
Safety
Safety
76 89 91 68
Sentiment
29 86 87 50
360° View
360° View
28 74 80 40
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
24 75 49 69
Opinions Change
50 50 50 50
Pro Holdings
n/a 55 73 16
Market Pulse
72 85 93 64
Sentiment
29 86 87 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
54 41 39 45
Growth
19 29 41 15
Safety Safety
76 89 91 68
Combined
51 55 64 22
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
83 59 60 64
Price vs. Earnings (P/E)
1 7 5 4
Price vs. Book (P/B)
95 80 79 85
Dividend Yield
1 1 1 1
Value
54 41 39 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
57 15 18 45
Profit Growth
4 80 93 25
Capital Growth
45 24 29 1
Stock Returns
37 51 57 71
Growth
19 29 41 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
34 75 78 79
Refinancing
77 82 77 55
Liquidity
72 41 43 25
Safety Safety
76 89 91 68

Similar Stocks

Discover high‑ranked alternatives to Knight Therapeutics and broaden your portfolio horizons.

Trican

TOR:TCW
Country: Canada
Industry: Oil & Gas Equipment
Size: Medium
Full Stock Analysis

B2Gold

TOR:BTO
Country: Canada
Industry: Gold Production
Size: Large
Full Stock Analysis

Parex Resources

TOR:PXT
Country: Canada
Industry: Oil & Gas Production
Size: Medium
Full Stock Analysis

Harmony Biosciences Holdings

NMQ:HRMY
Country: USA
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The only above-average rank is Safety. All other ranks (Value, Growth, and Sentiment) are below average. As Safety is the least critical rank, there are few positive facts to support this stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: